Catalyst Wire Dossier Catalyst Wire Dossier

TRV130A

oliceridine · Trevena Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TRV130A, covering 2012-08-24 to 2012-08-24. Get the full timeline:

Most recent: Clinical Trial Update: Single Ascending Dose Study of Intravenous TRV130A in Healthy Adult Males [Phase 1]

See pricing